| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/13/2010 | US20100120885 Novel Derivatives of Psammaplin A, A Method For Their Synthesis And Their Uses For The Prevention Or Treatment Of Cancer |
| 05/13/2010 | US20100120856 Derivatives of the Aminated Hydroxyquinoline Class For Treating Cancers |
| 05/13/2010 | US20100120854 Tgf-beta inhibitors |
| 05/13/2010 | US20100120849 Compositions for Treating Hyperproliferative Vascular Disorders and Cancers |
| 05/13/2010 | US20100120840 tyrosine kinase inhibitors such as 1-Phenyl-ethyl)-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-amine, used in the prevention and therapy of transplant rejection, inflammatory bowel disease, arthritis, psoriasis, restenosis, asthma, stroke, osteoporosis, cancer, Alzheimer's and Parkinson's disease |
| 05/13/2010 | US20100120823 Method of treating basal cell carcinoma |
| 05/13/2010 | US20100120818 Substituted tetrahydropyrroloquinolines |
| 05/13/2010 | US20100120817 Azonafide derived tumor and cancer targeting compounds |
| 05/13/2010 | US20100120816 Camptothecin derivatives with antitumor activity |
| 05/13/2010 | US20100120810 Compounds and methods for modulating rho gtpases |
| 05/13/2010 | US20100120806 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 05/13/2010 | US20100120805 Fused Bicyclic and Tricyclic Pyrimidine Compounds as Tyrosine Kinase Inhibitors |
| 05/13/2010 | US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 05/13/2010 | US20100120799 Purine derivatives as immunomodulators |
| 05/13/2010 | US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 05/13/2010 | US20100120788 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells |
| 05/13/2010 | US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/13/2010 | US20100120781 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function |
| 05/13/2010 | US20100120777 Treatment of T-Cell Lymphoma using 10-propargyl-10-deazaaminopterin |
| 05/13/2010 | US20100120773 Method of treating disorders mediated by the fibroblast growth factor receptor |
| 05/13/2010 | US20100120771 Aurora kinase inhibitors from an encoded small molecule library |
| 05/13/2010 | US20100120770 Thiazolyl compounds useful as kinase inhibitors |
| 05/13/2010 | US20100120767 Pyrimidothiophene Compounds |
| 05/13/2010 | US20100120766 Substituted Pteridines |
| 05/13/2010 | US20100120762 Triazine derivatives as inhibitors of phosphodiesterases |
| 05/13/2010 | US20100120761 Bicyclic Heterocyclic Compounds as FGFR Inhibitors |
| 05/13/2010 | US20100120758 Reverse-turn mimetics and method relating thereto |
| 05/13/2010 | US20100120756 Phenothiazine modulators of h1 receptors |
| 05/13/2010 | US20100120755 Conjugated psychotropic drugs and uses thereof |
| 05/13/2010 | US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors |
| 05/13/2010 | US20100120739 Triazolopyridazine protein kinase modulators |
| 05/13/2010 | US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives |
| 05/13/2010 | US20100120727 Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof |
| 05/13/2010 | US20100120722 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 05/13/2010 | US20100120719 Lyophilization formulation |
| 05/13/2010 | US20100120717 Kinase inhibitors |
| 05/13/2010 | US20100120708 Combination therapy comprising ZD6474 and gemcitabine for anti-cancer therapy |
| 05/13/2010 | US20100120705 Compositions and products containing s-equol, and methods for their making |
| 05/13/2010 | US20100120703 Compositions and methods for treating cancer |
| 05/13/2010 | US20100120697 Tumor Activated Prodrugs |
| 05/13/2010 | US20100120695 Polypeptides that bind membrane proteins |
| 05/13/2010 | US20100120694 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 05/13/2010 | US20100120693 Medicament for improving prognostic survival in therapy of malignant tumor |
| 05/13/2010 | US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof |
| 05/13/2010 | US20100120687 Modulating apoptosis |
| 05/13/2010 | US20100120685 Methods and compositions for the treatment of cancer |
| 05/13/2010 | US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 05/13/2010 | US20100120683 Prame derived peptides and immunogenic compositions comprising these |
| 05/13/2010 | US20100120681 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 05/13/2010 | US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 05/13/2010 | US20100120666 Methods of treatment using glycopegylated g-csf |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120070 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/13/2010 | US20100119610 Packaged pegylated gold nanoparticles |
| 05/13/2010 | US20100119601 Melatonin tablet and methods of preparation and use |
| 05/13/2010 | US20100119592 Cytarabine for treatment of glioma |
| 05/13/2010 | US20100119591 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer |
| 05/13/2010 | US20100119590 Method of drug loading in liposomes by gradient |
| 05/13/2010 | US20100119587 Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation |
| 05/13/2010 | US20100119574 Recombinant Gelatins |
| 05/13/2010 | US20100119572 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same |
| 05/13/2010 | US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2010 | US20100119548 Injecting directly into a tumor; cancer vaccine |
| 05/13/2010 | US20100119537 Tumor vaccine |
| 05/13/2010 | US20100119530 Regulation of TLR Signaling by Complement |
| 05/13/2010 | US20100119529 Elastin-like polymer delivery vehicles |
| 05/13/2010 | US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119514 Antibodies Against Cancer |
| 05/13/2010 | US20100119511 Light targeting molecules and uses thereof |
| 05/13/2010 | US20100119505 Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119475 Novel inhibitors of glutaminyl cyclase |
| 05/13/2010 | US20100119457 Composition of labeled and non-labeled monoclonal antibodies |
| 05/13/2010 | US20100119452 Screening method |
| 05/13/2010 | US20100119444 Tumor-Targeting Peptides and Uses Thereof |
| 05/12/2010 | EP2184355A1 Antibody modified with hydrophobic molecule |
| 05/12/2010 | EP2184352A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |
| 05/12/2010 | EP2184295A1 Polypeptides having anticancer activity |
| 05/12/2010 | EP2184285A1 Heterocyclic compound and use thereof |
| 05/12/2010 | EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators |
| 05/12/2010 | EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor |
| 05/12/2010 | EP2183393A1 Microrna signatures in human ovarian cancer |
| 05/12/2010 | EP2183361A1 Novel immunotherapy against neuronal and brain tumors |
| 05/12/2010 | EP2183272A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 05/12/2010 | EP2183267A2 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl) nonyl]estra-1,3,5(10)-triene-3,17-beta-diol |
| 05/12/2010 | EP2183261A1 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 05/12/2010 | EP2183256A1 Therapeutic compounds |
| 05/12/2010 | EP2183254A1 Inhibitors of protein tyrosine kinase activity |
| 05/12/2010 | EP2183251A1 Indazole compounds for treating inflammatory disorders, demyelinating disorders and cancers |
| 05/12/2010 | EP2183248A2 Benzimidazole poly (adp ribose) polymerase inhibitors |
| 05/12/2010 | EP2183243A2 Pyrazole compounds and their use as raf inhibitors |
| 05/12/2010 | EP2183242A2 Pyrimidine derivatives 934 |
| 05/12/2010 | EP2183233A1 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 05/12/2010 | EP2183232A2 Pi3 kinase modulators and methods of use |
| 05/12/2010 | EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 05/12/2010 | EP2183221A1 New compounds as hsp90 inhibitors |
| 05/12/2010 | EP2182987A1 Immune system modulator formulation |
| 05/12/2010 | EP2182982A2 Therapeutic use of anti-tweak receptor antibodies |
| 05/12/2010 | EP2182981A2 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |